Top Markets
#1 MowCat MowCat +48.86%
#2 Derive Derive +27.61%
#3 Geodnet Geodnet +18.75%
#4 Cross Cross +16.10%
#5 Audiera Audiera +13.75%
#6 Humanity Humanity +11.31%
#7 aPriori aPriori +11.31%
#8 Biconomy Biconomy +10.96%
#9 Quack AI Quack AI +9.85%
#10 Cap Cap +9.35%
Coin of the day
MowCat MowCat
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Telo Genomics Corp. Telo Genomics Corp.

Telo Genomics Corp.

TELO
Classifica tra le azioni #35884
Telo Genomics Corp. (TELO.V) operates as a biotechnology firm focused on... Telo Genomics Corp. (TELO.V) operates as a biotechnology firm focused on creating and bringing to market advanced predictive solutions. Its core mission is to enable personalized treatment approaches for individuals suffering from specific health conditions. The company's primary innovation is a sophisticated telomere analysis platform, which serves both to diagnose diseases and to forecast patient outcomes. This technology, often integrated with liquid biopsies, provides crucial insights for applications in both cancer and neurological illnesses. Their leading product, Telo-MM, is specifically designed to arm medical professionals with vital, actionable information for effectively managing Multiple Myeloma, a serious blood cancer. Additionally, Telo Genomics offers TeloView, a proprietary software system capable of precisely measuring individual patient telomere characteristics. Telo Genomics caters to a broad spectrum of clients, including diagnostic pathologists, clinical doctors, academic researchers, and pharmaceutical developers. A notable endorsement of its technology is a collaborative agreement with the renowned Mayo Clinic, aimed at validating the Telo-MM diagnostic tests for multiple myeloma. Founded in 2014 and based in Toronto, Canada, the company adopted its current name, Telo Genomics Corp., in April 2019, having previously operated as 3D Signatures Inc.
Prezzo delle azioni
$0.03302716
Ultima sincronizzazione: 2026-08-13
Capitalizzazione di mercato
$3.32M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-34.80%
Paese
CA
Scambia Telo Genomics Corp. (TELO)

Categoria

Healthcare
Cronologia dei frazionamenti azionari per Telo Genomics Corp. (TELO)
L’azione Telo Genomics Corp. (simbolo: TELO) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Aug 16, 2026.
Una quota di TELO acquistata prima di Aug 16, 2026 equivale oggi a 0 quote di TELO.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 8 x34
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 7 x47
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 0 -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 0 -
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 4 x15
US